Related Experiment Video

Updated: May 28, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

HIV/hepatitis C coinfection natural history and disease progression

Maria D Hernandez1, Kenneth E Sherman

  • 1Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA.

Current Opinion in HIV and AIDS
|October 18, 2011
PubMed

Insights

Treating HIV early in patients coinfected with hepatitis C virus (HCV) can slow liver disease progression. Antiretroviral therapy (ART) for HIV may also improve outcomes for HCV treatment.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Immunology

Background:

  • Hepatitis C virus (HCV) coinfection affects up to one-third of HIV-infected patients.
  • HIV accelerates HCV-related chronic liver disease progression.
  • Antiretroviral therapy (ART) has improved HIV survival, making liver disease a leading threat for coinfected individuals.

Purpose of the Study:

  • To review the impact of HIV on HCV pathogenesis and liver disease progression.
  • To evaluate the role of early ART in managing HIV/HCV coinfection.
  • To assess the benefits of early anti-HCV treatment in coinfected patients.

Main Methods:

  • Review of recent studies on HIV/HCV coinfection.
  • Analysis of the effects of ART on liver disease progression.
  • Evaluation of treatment strategies for coinfected patients.

Main Results:

  • Early ART initiation limits liver disease progression in coinfected patients.
  • HIV coinfection negatively impacts HCV pathogenesis.
  • Successful ART may reduce chronic liver disease progression and improve anti-HCV therapy response, despite hepatotoxicity risks.

Conclusions:

  • HIV significantly influences the rate of liver disease progression in coinfected individuals.
  • HIV treatment can potentially slow disease progression and reduce liver mortality.
  • Early intervention for both HIV and HCV is crucial for improved patient outcomes.
Abstract

More Related Videos

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...